Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

504 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A balanced review of the status T cell-based therapy against cancer.
Marincola FM. Marincola FM. J Transl Med. 2005 Apr 14;3(1):16. doi: 10.1186/1479-5876-3-16. J Transl Med. 2005. PMID: 15831096 Free PMC article.
Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35).
Loftus DJ, Castelli C, Clay TM, Squarcina P, Marincola FM, Nishimura MI, Parmiani G, Appella E, Rivoltini L. Loftus DJ, et al. Among authors: marincola fm. J Exp Med. 1996 Aug 1;184(2):647-57. doi: 10.1084/jem.184.2.647. J Exp Med. 1996. PMID: 8760818 Free PMC article.
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.
Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Dudley ME, Schwarz SL, Spiess PJ, Wunderlich JR, Parkhurst MR, Kawakami Y, Seipp CA, Einhorn JH, White DE. Rosenberg SA, et al. Among authors: marincola fm. Nat Med. 1998 Mar;4(3):321-7. doi: 10.1038/nm0398-321. Nat Med. 1998. PMID: 9500606 Free PMC article. Clinical Trial.
Cancer therapy using a self-replicating RNA vaccine.
Ying H, Zaks TZ, Wang RF, Irvine KR, Kammula US, Marincola FM, Leitner WW, Restifo NP. Ying H, et al. Among authors: marincola fm. Nat Med. 1999 Jul;5(7):823-7. doi: 10.1038/10548. Nat Med. 1999. PMID: 10395329 Free PMC article.
Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression.
Lee KH, Wang E, Nielsen MB, Wunderlich J, Migueles S, Connors M, Steinberg SM, Rosenberg SA, Marincola FM. Lee KH, et al. Among authors: marincola fm. J Immunol. 1999 Dec 1;163(11):6292-300. J Immunol. 1999. PMID: 10570323 Clinical Trial.
Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma.
Ohnmacht GA, Marincola FM. Ohnmacht GA, et al. Among authors: marincola fm. J Cell Physiol. 2000 Mar;182(3):332-8. doi: 10.1002/(SICI)1097-4652(200003)182:3<332::AID-JCP3>3.0.CO;2-Z. J Cell Physiol. 2000. PMID: 10653599 Review.
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma.
Dudley ME, Wunderlich J, Nishimura MI, Yu D, Yang JC, Topalian SL, Schwartzentruber DJ, Hwu P, Marincola FM, Sherry R, Leitman SF, Rosenberg SA. Dudley ME, et al. Among authors: marincola fm. J Immunother. 2001 Jul-Aug;24(4):363-73. doi: 10.1097/00002371-200107000-00012. J Immunother. 2001. PMID: 11565838 Clinical Trial.
T-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance.
Phan GQ, Wang E, Marincola FM. Phan GQ, et al. Among authors: marincola fm. Expert Opin Biol Ther. 2001 May;1(3):511-23. doi: 10.1517/14712598.1.3.511. Expert Opin Biol Ther. 2001. PMID: 11727522 Review.
The role of quantitative PCR for the immune monitoring of cancer patients.
Panelli MC, Wang E, Monsurro V, Marincola FM. Panelli MC, et al. Among authors: marincola fm. Expert Opin Biol Ther. 2002 Jun;2(5):557-64. doi: 10.1517/14712598.2.5.557. Expert Opin Biol Ther. 2002. PMID: 12079490 Review.
504 results
Jump to page
Feedback